AIFM2 and non-small cell lung carcinoma: A recent study focusing on KEAP1-mutant non-small cell lung cancer (NSCLC) found that FSP1 expression was partially dependent on NRF2 [63], though NRF2 inhibition alone did not significantly reduce FSP1 protein levels.